NCT05610956 Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis Status RECRUITING Phase EARLY_PHASE1
NCT05606939 The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative Colitis Status UNKNOWN Phase N/A
NCT05598684 SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases Status RECRUITING Phase N/A
NCT05598489 Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT05596422 A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase N/A
NCT05587673 High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase PHASE1
NCT05579483 Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures Status NOT_YET_RECRUITING Phase NA
NCT05570006 Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT05549323 A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis Status TERMINATED Phase PHASE1
NCT05539625 Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Status WITHDRAWN Phase PHASE2
NCT05507216 ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 Status COMPLETED Phase PHASE3
NCT05507203 ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 Status COMPLETED Phase PHASE3
NCT05500040 Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation Status COMPLETED Phase N/A